| Literature DB >> 33328620 |
Mehmet Ali Karagöz1, Abdullah Gül2, Charmaine Borg3, İsmet Bilger Erihan4, Mehmet Uslu4, Mehmet Ezer4, Ahmet Erbağcı4, Binali Çatak5, Murat Bağcıoğlu4.
Abstract
Coronavirus disease 2019 (COVID-19) pandemic has been continuing to affect the lives of all people globally. It has been shown that restrictions due to changes in lifestyles lead to mental health problems. This study aims to investigate the effect of COVID-19 pandemic on couples' sexuality. A total of 245 volunteers (148 men and 97 women) were enrolled in the study. Generalized Anxiety Disorder-7, Patient Health Questionnaire, Perceived Stress Scale were administered to screen anxiety and depression symptoms. International Index of Erectile Function (IIEF-15) and Female Sexual Function Index (FSFI) along with self-constructed sexual behavior questionnaire were administered to participants, in order to evaluate sexual functions and behavioral changes during the pandemic. Sexual function scores (IIEF erectile function domain and total FSFI) during pandemic (24.55 ± 5.79 and 24.87 ± 7.88, respectively) were lower compared to the prepandemic period (26.59 ± 4.51 and 26.02 ± 6.22, respectively) (p = 0.001 and p = 0.027, respectively). During pandemic compared to prepandemic period, the frequency of sexual intercourse decreased in men (p = 0.001) and women (p = 0.001) while sexual avoidance and solitary sexual approach behaviors (masturbation or watching sexual content videos, etc.) increased in men (p = 0.001) and women (p = 0.022). However, the couples that spent more time together during the pandemic reported better sexual function scores (men; p = 0.001, women; p = 0.006). Although this is the first study evaluating couples from Turkey with a convenience sample, further studies with a greater number may better elucidate the effects of this pandemic on sexuality.Entities:
Mesh:
Year: 2020 PMID: 33328620 PMCID: PMC7739794 DOI: 10.1038/s41443-020-00378-4
Source DB: PubMed Journal: Int J Impot Res ISSN: 0955-9930 Impact factor: 2.408
Demographics and psychological status of the participants.
| Variables | Total ( | Female ( | Male ( | Female vs. male |
|---|---|---|---|---|
| Age, year (mean ± SD) | 35.9 ± 6.9 | 34.7 ± 6.67 | 36.7 ± 7.1 | 0.032a |
| Height, cm (mean ± SD) | 172.7 ± 8.7 | 164.5 ± 5.65 | 178.1 ± 5.7 | 0.001a |
| Weight, kg (mean ± SD) | 76.9 ± 15.4 | 65.8 ± 12.41 | 84.2 ± 12.7 | 0.001a |
| BMI, kg/m2 (mean ± SD) | 25.61 ± 3.94 | 24.25 ± 4.15 | 26.51 ± 3.54 | 0.001a |
| Smoker, | 95 (38.8) | 25 (25.8) | 70 (47.3) | 0.001a |
| Alcohol consumer, | 85 (34.7) | 23 (23.7) | 62 (41.9) | 0.003a |
| Regular exercise, | 74 (30.2) | 23 (23.7) | 51 (34.5) | 0.073 |
| Education level, | 0.001a | |||
| Primary school | 2 (0.8) | 0 (0) | 2 (1.4) | |
| High school | 32 (13.1) | 9 (9.3) | 23 (15.5) | |
| University | 136 (55.5) | 65 (67) | 71 (48) | |
| Post graduate/PhD | 75 (30.6) | 23 (23.7) | 52 (35.1) | |
| Comorbidities, | 38 (15.5) | 21 (21.6) | 17 (11.5) | 0.032a |
| Hypertension | 11 (4.5) | 2 (2.1) | 9 (6.1) | 0.137 |
| Diabetes mellitus | 12 (4.9) | 3 (3.1) | 9 (6.1) | 0.289 |
| Hyperlipidemia | 3 (1.2) | 2 (2.1) | 1 (0.7) | 0.564 |
| Coronary artery disease | 1 (0.4) | 0 (0) | 1 (0.7) | 0.417 |
| Other | 20 (8.2) | 16 (16.5) | 4 (2.7) | 0.001a |
| Medication usage, | 40 (16.3) | 28 (28.9) | 12 (8.1) | 0.001a |
| Duration of marriage/partnership, | 0.233 | |||
| ≤1 year | 25 (10.2) | 7 (7.2) | 18 (12.2) | |
| 1–5 years | 74 (30.2) | 32 (33) | 42 (28.4) | |
| 5–10 years | 67 (27.3) | 22 (22.7) | 45 (30.4) | |
| ≥10 years | 79 (32.2) | 36 (37.1) | 43 (29.1) | |
| Negative effect of pandemic on economic status, | 0.359 | |||
| None | 125 (51) | 50 (51.5) | 75 (50.7) | |
| Mild | 57 (23.3) | 22 (22.7) | 35 (23.6) | |
| Moderate | 48 (19.6) | 22 (22.7) | 26 (17.6) | |
| Severe | 15 (6.1) | 3 (1.2) | 12 (8.1) | |
| GAD-7 score, | 0.001a | |||
| No anxiety | 70 (28.6) | 15 (15.5) | 55 (37.2) | |
| Mild anxiety | 135 (55.1) | 58 (59.8) | 77 (52) | |
| Moderate anxiety | 32 (13.1) | 19 (19.6) | 13 (8.8) | |
| Severe anxiety | 8 (3.3) | 5 (5.2) | 3 (2) | |
| PHQ-9 score, | 0.001a | |||
| No depression | 49 (20) | 10 (10.3) | 39 (26.4) | |
| Mild depression | 134 (54.7) | 50 (51.5) | 84 (56.8) | |
| Moderate depression | 39 (15.9) | 24 (24.7) | 15 (10.1) | |
| Moderate to severe depression | 21 (8.6) | 11 (11.3) | 10 (6.8) | |
| Severe depression | 2 (0.8) | 2 (2.1) | 0 (0) | |
| PSS score (mean ± SD) | 24.06 ± 7.20 | 26.95 ± 6.80 | 22.16 ± 6.84 | 0.001a |
| GAD-7 score (mean ± SD) | 6.49 ± 3.64 | 7.56 ± 3.74 | 5.8 ± 3.4 | 0.001a |
| PHQ-9 score (mean ± SD) | 7.79 ± 4.32 | 9.17 ± 4.59 | 6.89 ± 3.9 | 0.001a |
GAD-7 Generalized Anxiety Disorder Score, PHQ-9 score Patient Health Questionnaire score, PSS Perceived Stress Scale score.
aSignificant at 0.05 level. Student’s t test and Mann–Whitney U test for numerical, Chi-square test for categorical data.
Changes of sexual behaviors during COVID-19 pandemic.
| Variables | Total ( | Female ( | Male ( | Female vs. male |
|---|---|---|---|---|
| Spending more time with partner, | 186 (75.9) | 74 (76.3) | 112 (75.7) | 0.913 |
| Effect of restrictions and limitations on your daily and emotional relationships, | 0.910 | |||
| No difference | 122 (49.8) | 47 (48.5) | 75 (50.7) | |
| Positively | 78 (31.8) | 31 (32) | 47 (31.8) | |
| Negatively | 45 (18.4) | 19 (19.6) | 26 (17.6) | |
| Sexual avoidance behaviors towards your partner, | 66 (26.9) | 37 (38.1) | 29 (19.6) | 0.001a |
| Considering that you could be infected during intercourse, | 55 (22.0) | 31 (32.0) | 23 (15.5) | 0.002a |
| Considering that partner has sexual avoidance behaviors, | 38 (15.5) | 15 (15.5) | 23 (15.5) | 0.987 |
| Being insightful of partners sexual avoidance behaviors, | 128 (52.2) | 49 (50.5) | 79 (53.4) | 0.883 |
| Taking precautions during intercourse, | 24 (9.8) | 14 (14.4) | 10 (6.8) | 0.048a |
| Increase in solitary sexual satisfaction approach (masturbation, video etc), | 23 (9.4) | 4 (4.1) | 19 (12.8) | 0.022a |
| New onset of solitary sexual satisfaction approach, | 10 (4.1) | 5 (5.2) | 5 (3.4) | 0.492 |
aSignificant at 0.05 level. Chi-square test.
Comparison of intercourse frequencies before and during COVID-19 pandemic.
| Frequency of intercourse per week | Female | Male | ||||
|---|---|---|---|---|---|---|
| Before pandemic | During pandemic | Before pandemic | During pandemic | |||
| 0.001a | 0.001a | |||||
| ≤1 | 17 (17.5) | 40 (41.2) | 28 (18.9) | 67 (45.3) | ||
| 2 | 47 (48.5) | 33 (34) | 66 (44.6) | 41 (27.7) | ||
| 2–5 | 29 (29.9) | 21 (21.6) | 48 (32.4) | 30 (20.3) | ||
| ≥5 | 4 (4.1) | 3 (3.1) | 6 (4.1) | 10 (6.8) | ||
aSignificant at 0.05 level, Wilcoxon signed rank test.
Comparison of IIEF-15 scores before and during COVID-19 pandemic in men (n = 148).
| IIEF domains | Before pandemic (mean ± SD) | During pandemic (mean ± SD) | |
|---|---|---|---|
| Erectile function | 26.59 ± 4.51 | 24.55 ± 5.79 | 0.001a |
| Orgasmic function | 9.11 ± 1.37 | 8.64 ± 2.3 | 0.014a |
| Sexual desire | 7.75 ± 1.49 | 7.57 ± 1.82 | 0.173 |
| Intercourse satisfaction | 11.53 ± 2.32 | 10.66 ± 3.64 | 0.001a |
| Overall satisfaction | 8.58 ± 1.66 | 8.04 ± 2.16 | 0.001a |
IIEF International Index of Erectile Function.
aSignificant at 0.05 level, Wilcoxon test.
Comparison of FSFI scores before and during COVID-19 pandemic in women (n = 97).
| FSFI domains | Before pandemic (mean ± SD) | During pandemic (mean ± SD) | |
|---|---|---|---|
| Total Score | 26.02 ± 6.22 | 24.87 ± 7.88 | 0.027a |
| Desire | 3.77 ± 1.08 | 3.74 ± 1.33 | 0.646 |
| Arousal | 4.01 ± 1.19 | 3.80 ± 1.51 | 0.103 |
| Lubrication | 4.77 ± 1.15 | 4.55 ± 1.48 | 0.034a |
| Orgasm | 4.25 ± 1.43 | 4.04 ± 1.61 | 0.023a |
| Satisfaction | 4.41 ± 1.35 | 4.11 ± 1.53 | 0.007a |
| Pain | 4.78 ± 1.42 | 4.60 ± 1.58 | 0.065 |
| FSFI < 26.55 (%) | 45.4 | 52.6 | 0.001a |
FSFI Female Sexual Function Index.
aSignificant at 0.05 level, Wilcoxon test, and Chi-square test.
Correlations of IIEF-15 domains with age, economic loss, GAD-7, PHQ-9, and PSS.
| Correlation factors | Erectile function | Orgasmic function | Sexual desire | Intercourse satisfaction | Overall satisfaction |
|---|---|---|---|---|---|
| Age | |||||
| Economic loss | |||||
| GAD-7 score (%) | |||||
| PHQ-9 score (%) | |||||
| PSS score |
IIEF International Index of Erectile Function, GAD-7 Generalized Anxiety Disorder Score, PHQ-9 Score Patient Health Questionnaire Score, PSS Perceived Stress Scale Score.
aSignificant at 0.05 level, Spearman rank correlation coefficient.
Correlations of total FSFI score and FSFI domains with age, economic loss, GAD-7, PHQ-9, and PSS.
| Correlation factors | FSFI desire | FSFI arousal | FSFI lubrication | FSFI orgasm | FSFI satisfaction | FSFI pain | FSFI total |
|---|---|---|---|---|---|---|---|
| Age | |||||||
| Economic loss | |||||||
| GAD-7 score | |||||||
| PHQ-9 score | |||||||
| PSS score |
FSFI Female Sexual Function Index, GAD-7 Generalized Anxiety Disorder Score, PHQ−9 Score Patient Health Questionnaire Score, PSS Perceived Stress Scale Score.
aSignificant at 0.05 level, Spearman rank correlation coefficient.